|
RAB5A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.358300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.696400E-02 |
| Normal-vs-Stage2 |
2.960800E-01 |
| Normal-vs-Stage3 |
3.233000E-01 |
| Normal-vs-Stage4 |
2.061800E-02 |
| Stage1-vs-Stage2 |
8.662600E-01 |
| Stage1-vs-Stage3 |
8.292600E-01 |
| Stage1-vs-Stage4 |
4.283600E-01 |
| Stage2-vs-Stage3 |
9.843400E-01 |
| Stage2-vs-Stage4 |
4.225000E-01 |
| Stage3-vs-Stage4 |
4.692200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.295500E-02 |
| Normal-vs-AfricanAmerican |
5.428200E-01 |
| Normal-vs-Asian |
2.011800E-01 |
| Caucasian-vs-AfricanAmerican |
2.435200E-01 |
| Caucasian-vs-Asian |
9.024200E-01 |
| AfricanAmerican-vs-Asian |
6.097000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.502400E-03 |
| Normal-vs-Female |
4.774600E-01 |
| Male-vs-Female |
3.538100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.002000E-02 |
| Normal-vs-Extreme_Weight |
2.956600E-03 |
| Normal-vs-Obese |
6.662600E-01 |
| Normal-vs-Extreme_Obese |
5.489600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.517600E-01 |
| Normal_Weight-vs-Obese |
1.384560E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.249400E-01 |
| Extreme_Weight-vs-Obese |
3.669900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.906800E-01 |
| Obese-vs-Extreme_Obese |
6.996800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.192400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.183400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.142100E-03 |
| Normal-vs-Age(81-100Yrs) |
6.106400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.130800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.242300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.402770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.543900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.880400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.423600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.736600E-01 |
| Normal-VS-Type2 PRCC |
2.47729999999224E-05 |
| Normal-VS-KIRP CIMP |
1.376390E-02 |
| Normal-VS-Unclassified PRCC |
5.606800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.174100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.377340E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.302800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.61299999976461E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.495840E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.781400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.150210E-04 |
| Normal-vs-N1 |
7.497200E-01 |
| Normal-vs-N2 |
2.879600E-01 |
| N0-vs-N1 |
2.028200E-02 |
| N0-vs-N2 |
9.221000E-01 |
| N1-vs-N2 |
3.074600E-01 |
|
|
